| Record ID | ia:pathophysiologyp0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/pathophysiologyp0000unse/pathophysiologyp0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/pathophysiologyp0000unse/pathophysiologyp0000unse_meta.mrc |
LEADER: 03548cam 2200829 a 4500
001 ocm25869713
003 OCoLC
005 20200511011347.0
008 920506s1992 gw a b 101 0 eng
010 $a 92002312
040 $aDNLM/DLC$beng$cDLC$dNLM$dUKM$dOCLCQ$dBAKER$dBTCTA$dOCLCG$dYDXCP$dGEBAY$dDEBBG$dTPH$dBDX$dOCLCO$dOCLCQ$dOCLCF$dOCLCO$dOCLCA
015 $aGB9306611$2bnb
016 7 $a9206577$2DNLM
019 $a25876901$a26893536
020 $a3540547770$q(Berlin)
020 $a9783540547778$q(Berlin)
020 $a0387547770$q(New York)
020 $a9780387547770$q(New York)
035 $a(OCoLC)25869713$z(OCoLC)25876901$z(OCoLC)26893536
050 10 $aRM666.E834$bP37 1992
060 00 $aWH 150$bP297 1992
082 00 $a615/.718$220
084 $aWD 5836$2rvk
245 00 $aPathophysiology and pharmacology of erythropoietin /$cHorst Pagel, Christoph Weiss, Wolfgang Jelkmann (eds.).
260 $aBerlin ;$aNew York :$bSpringer-Verlag,$c℗♭1992.
300 $axv, 328 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
650 0 $aErythropoietin$xTherapeutic use$vCongresses.
650 0 $aErythropoietin$xPathophysiology$vCongresses.
650 0 $aRecombinant erythropoietin$xTherapeutic use$vCongresses.
650 0 $aRecombinant erythropoietin$xPathophysiology$vCongresses.
650 0 $aRenal anemia$xChemotherapy$vCongresses.
650 0 $aAnemia$xChemotherapy$vCongresses.
650 7 $aAna mie$2gnd
650 7 $aChronische Niereninsuffizienz$2gnd
650 7 $aErythropoietin$2gnd
650 7 $aPathophysiologie$2gnd
650 7 $aPharmakologie$2gnd
650 7 $aRekombinantes Protein$2gnd
650 7 $aKongress$2gnd
651 7 $aLu beck$2gnd
650 7 $aAnemia$xChemotherapy.$2fast$0(OCoLC)fst00808619
650 7 $aErythropoietin$xTherapeutic use.$2fast$0(OCoLC)fst00915097
650 7 $aRecombinant erythropoietin$xTherapeutic use.$2fast$0(OCoLC)fst01091490
650 7 $aRenal anemia$xChemotherapy.$2fast$0(OCoLC)fst01094531
650 2 $aAnemia$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D000740Q000188
650 2 $aErythropoietin$xphysiology.$0https://id.nlm.nih.gov/mesh/D004921Q000502
650 2 $aErythropoietin$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D004921Q000627
650 2 $aKidney Failure, Chronic$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D007676Q000188
650 2 $aRecombinant Proteins$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D011994Q000627
653 0 $aHumans$aAnaemia
655 4 $aKongress (Lu beck)
655 4 $aKongre©
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aPagel, Horst.
700 1 $aWeiss, Christoph.
700 1 $aJelkmann, Wolfgang,$d1949-
776 08 $iOnline version:$tPathophysiology and pharmacology of erythropoietin.$dBerlin ; New York : Springer-Verlag, ℗♭1992$w(OCoLC)608204541
938 $aBaker & Taylor$bBKTY$c100.00$d100.00$i0387547770$n0002132025$sactive
938 $aBrodart$bBROD$n44911785$c$79.00
938 $aBaker and Taylor$bBTCP$n92002312
938 $aYBP Library Services$bYANK$n7823833
029 1 $aAU@$b000024885975
029 1 $aDEBBG$bBV005420234
029 1 $aGEBAY$b1700597
029 1 $aNLM$b9206577
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 49 OTHER HOLDINGS